Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett A Schroeder

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Oncoimmunology|February 1, 2020
Durable tumor regression in highly refractory metastatic <i>KIT/PDGFRA</i> wild-type GIST following treatment with nivolumabBrett A Schroeder, Karan Kohli, Ryan B O'Malley, et al.
Cancers|April 23, 2022
Novel Targeted Therapeutic Strategies for Ewing SarcomaDaria Fayzullina, Sergey Tsibulnikov, Mikhail Stempen, et al.
Cancers|November 14, 2023
Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor CellsDarya Fayzullina, Semyon Yakushov, Kamilla Kantserova, et al.
Journal for Immunotherapy of Cancer|April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapyBrett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.
Cancers|March 10, 2022
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma PatientsBrett A Schroeder, Yuzheng Zhang, Kimberly S Smythe, et al.
Journal for Immunotherapy of Cancer|September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomesBrett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapyKaran Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Molecular Cancer Therapeutics|April 11, 2022
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma ModelShihong Zhang, R Graeme Black, Karan Kohli, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oncoimmunology|February 1, 2020
Durable tumor regression in highly refractory metastatic <i>KIT/PDGFRA</i> wild-type GIST following treatment with nivolumabBrett A Schroeder, Karan Kohli, Ryan B O'Malley, et al.
Cancers|April 23, 2022
Novel Targeted Therapeutic Strategies for Ewing SarcomaDaria Fayzullina, Sergey Tsibulnikov, Mikhail Stempen, et al.
Cancers|November 14, 2023
Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor CellsDarya Fayzullina, Semyon Yakushov, Kamilla Kantserova, et al.
Journal for Immunotherapy of Cancer|April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapyBrett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.
Cancers|March 10, 2022
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma PatientsBrett A Schroeder, Yuzheng Zhang, Kimberly S Smythe, et al.
Journal for Immunotherapy of Cancer|September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomesBrett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapyKaran Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Molecular Cancer Therapeutics|April 11, 2022
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma ModelShihong Zhang, R Graeme Black, Karan Kohli, et al.
Pageof 3